GLORIA MELANIE (Chief Operating Officer) sold 1.0% of their position (2.24K shares) of IMMUNOVANT, INC. on the open market
Open‑market sale worth $71.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/9/2026ACC: 0001764013-26-000112
Officer· Chief Operating Officer
Since Feb 2026
-2.24K
Net shares
Net seller
$71.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2.24K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.24K
Price / share
$32.06
Trade value
$71.85K
% of position
1.0%
10/7/2026
219.30K→217.06K
Total
Net shares
−2.24K
Net value
-$71.85K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/7/2026 | S · Sale | −2.24K | $32.06 | $71.85K | 1.0% | 219.30K | 217.06K |
| Total | −2.24K | -$71.85K | ||||||
Derivative Transactions0
No derivative transactions reported